Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» OncoMed's pancreatic cancer drug fails mid-stage study
OncoMed's pancreatic cancer drug fails mid-stage study
OncoMed's pancreatic cancer drug fails mid-stage study
Submitted by
admin
on April 10, 2017 - 11:00am
Source:
Yahoo/Reuters
News Tags:
OncoMed
pancreatic cancer
clinical trials
Celgene
Abraxane
demcizumab
Headline:
OncoMed's pancreatic cancer drug fails mid-stage study
Do Not Allow Advertisers to Use My Personal information
